Steven L. Bender

4.2k citations

26 papers · 2.1k indexed · 2 hit papers · h-index 16

Impact in

Organic Chemistry top 2%
- Synthetic Organic Chemistry Methods
- Carbohydrate Chemistry and Synthesis
Hepatology top 5%
- Liver physiology and pathology

Papers in

Toxicology 2
Organic Chemistry 10
- Synthesis and Reactivity of Heterocycles 4
- Synthesis and Reactions of Organic Compounds 2

Co-authors: Robert E. Babine David A. Evans Jeremy R. Knowles Joel Morris Theodore S. Widlanski James G. Christensen Joseph H. Lee Gerrit Los
Journals: Cancer Research (7 papers)Journal of the American Chemical Society (4 papers)Tetrahedron Letters (4 papers)The Journal of Organic Chemistry (3 papers)Biochemistry (2 papers)
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Steven L. Bender

26 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms 2007 · 593 citations

Peers

Countries citing papers authored by Steven L. Bender

Since Specialization

Citations

This map shows the geographic impact of Steven L. Bender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven L. Bender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven L. Bender more than expected).

Fields of papers citing papers by Steven L. Bender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven L. Bender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven L. Bender. The network helps show where Steven L. Bender may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven L. Bender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven L. Bender Line = papers co-authored together Steven L. Bender links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract PR09: ADU-S100 (MIW815) synergizes with checkpoint blockade to elicit an antitumor CD8+ T-cell response to control distal tumors Cancer Immunology Research ·Weiwen Deng, Anthony L. Desbien, 왕귀상, Gabrielle L. Reiner, Leticia Corrales, Claudia Matuschek, Laura Hix Glickman, Natalie H. Surh, Brian J. Francica, Justin J. Leong, Ken Metchette, Lianxing Zheng, Charles Cho, Feng Yan, Laiany Oliveira De Jesus, Steven L. Bender, Chudi Ndubaku, Meredith L. Leong, Andrea van Elsas, Sarah M. McWhirter	2020	4
2	Abstract 4128: Identification and characterization of LHC165, a TLR7 agonist designed for localized intratumoral therapies Cancer Research ·Jonathan A. Deane, Eva Alhava, Chun Li, Romain Sylvain, Shailaja Kasibhatla, Nehal S. Parikh, Shifeng Pan, Steven L. Bender	2019	9
3	Abstract 1734: In vitro characterization of EGF816, a third-generation mutant-selective EGFR inhibitor Cancer Research ·Yong Jia, Jose Juarez, Mari Manuia, G. Lelais, Shailaja Kasibhatla, Ranjan Modi, Matthew McNeill, Michael DiDonato, Badry Bursulaya, Debbie Liao, Eric A. Murphy, Robert Epple, Thomas H. Marsilje, Nazima Pathan, Pierre‐Yves Michellys, Steven L. Bender, Jennifer L. Harris	2014	4
4	Sensitivity of Selected Human Tumor Models to PF-04217903, a Novel Selective c-Met Kinase Inhibitor Molecular Cancer Therapeutics ·Helen Y. Zou, Qiuhua Li, Joseph H. Lee, Maria E. Arango, T Iziana M Eschi, Ming Qiu, Lars D. Engstrom, Shinji Yamazaki, Hassan Shehata Hassan, Sergei Timofeevski, Jingrong Jean Cui, Michele McTigue, Gerrit Los, Steven L. Bender, Tod Smeal, James G. Christensen	2012	57
5	Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity Cancer Research ·Gang Li, Lianglin Zhang, Enhong Chen, Jianying Wang, Xin Jiang, Jeffrey H. Chen, Grant Wickman, Karin Amundson, Simon Bergqvist, James Zobel, Dan A. Chrisman, Sangita M. Baxi, Steven L. Bender, Gerald F. Casperson, Dana D. Hu‐Lowe	2010	20
6	An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms Cancer Research ·Helen Y. Zou, Qiuhua Li, Joseph H. Lee, Maria E. Arango, Scott R. McDonnell, Shinji Yamazaki, Tatiana Koudriakova, Gordon Alton, Jingrong Jean Cui, 隆真瓜生津, Mitchell D. Nambu, Gerrit Los, Steven L. Bender, Barbara Mroczkowski, James G. Christensen Hit paper breakdown →	2007	593
7	PF-00337210, a potent, selective and orally bioavailable small molecule inhibitor of VEGFR-2 Cancer Research ·Tami Marrone, Dana D. Hu‐Lowe, Maren L. Grazzini, Min-Jean Yin, Jeffrey Chen, Max Hallin, Karin Amundson, Shinji Yamazaki, David Romero, Aileen McHarg, Eileen Blasi, 渡邊美樹, Alexandre Cerveux, Cynthia L. Palmer, Judith G. Deal, Brion W. Murray, James Solowiej, Michele McTigue, John Wickersham, Steven L. Bender	2007	7
8	Discovery of novel intracellular receptor modulating drugs The Journal of Steroid Biochemistry and Molecular Biology ·Todd K. Jones, Charles Pathirana, Mark E. Goldman, Lawrence G. Hamann, Luc J. Farmer, 채옥삼, Michael G. Johnson, Steven L. Bender, Dale E. Mais, Robert B. Stein	1996	10
9	Synthesis and Biological Activity of Novel Nonsteroidal Progesterone Receptor Antagonists Based on Cyclocymopol Monomethyl Ether Journal of Medicinal Chemistry ·Lawrence G. Hamann, Luc J. Farmer, Michael G. Johnson, Steven L. Bender, Dale E. Mais, Ming‐Wei Wang, Diane L. Crombie, Mark E. Goldman, Todd K. Jones	1996	31
10	An approach to pancratistatin from myo-inositol Tetrahedron Letters ·Donald R. Gauthier, Steven L. Bender	1996	24
11	Synthesis and Biological Activity of Novel Nonsteroidal Progesterone Receptor Antagonists Annals of the New York Academy of Sciences ·Lawrence G. Hamann, Luc J. Farmer, Michael G. Johnson, Mark E. Goldman, Dale E. Mais, Gary S. Gelber, Steven L. Bender, Todd K. Jones	1995	5
12	Organocerium additions to 2'-deoxy-3'-ketonucleosides. The Journal of Organic Chemistry ·Steven L. Bender, P. Pardasani	1992	20
13	Biomimetic synthesis of enantiomerically pure D-myo-inositol derivatives Journal of the American Chemical Society ·Steven L. Bender, Richard J. Budhu	1991	64
14	Dehydroquinate synthase: the role of divalent metal cations and of nicotinamide adenine dinucleotide in catalysis Biochemistry ·Steven L. Bender, Shujaath Mehdi, Jeremy R. Knowles	1989	49
15	Dehydroquinate synthase: the use of substrate analogs to probe the early steps of the catalyzed reaction Biochemistry ·Steven L. Bender, Theodore S. Widlanski, Jeremy R. Knowles	1989	71
16	Dehydroquinate synthase: a sheep in wolf's clothing? Journal of the American Chemical Society ·Theodore S. Widlanski, Steven L. Bender, Jeremy R. Knowles	1989	50
17	The total synthesis of the polyether antibiotic X-206 Journal of the American Chemical Society ·David A. Evans, Steven L. Bender, Joel Morris	1988	183
18	Total synthesis of the ionophore antibiotic X-206. Studies relevant to the stereoselective synthesis of the C(17)–C(26) synthon. Tetrahedron Letters ·David A. Evans, Steven L. Bender	1986	49
19	Synthesis of 1-acyloxyindolizines. Correction of a structure misassignment Tetrahedron Letters ·D. H. WADSWORTH, Steven L. Bender, Douglas L. Smith, Henry R. Luss	1981	7
20	Synthesis of - and -2,4-dibenzylidine-1,3-ditelluretan from sodium phenyl acetylide and tellurium metal; a reinvestigation and structure proof Tetrahedron Letters ·Steven L. Bender, Neil F. Haley, Henry R. Luss	1981	19

About Steven L. Bender

Steven L. Bender is a scholar working on Toxicology, Organic Chemistry, Oncology, Hepatology and Molecular Biology, having authored 26 papers that have together received 2.1k indexed citations. Recurring topics across this work include Synthesis and Reactivity of Heterocycles (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Estrogen and related hormone effects (3 papers), interferon and immune responses (2 papers), Liver physiology and pathology (2 papers), Synthesis and Reactions of Organic Compounds (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Organic Chemistry (742 citations), Hepatology (195 citations), Oncology (581 citations), Cancer Research (257 citations) and Molecular Biology (1.1k citations). Steven L. Bender has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Robert E. Babine, David A. Evans, Jeremy R. Knowles, Joel Morris, Theodore S. Widlanski, James G. Christensen, Joseph H. Lee, Gerrit Los, Maria E. Arango and Qiuhua Li. Their work appears in journals such as Cancer Research, Journal of the American Chemical Society, Tetrahedron Letters, The Journal of Organic Chemistry and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact